China SXT Pharmaceuticals, Inc. (SXTC) vs VivoSim Labs, Inc. (VIVS)
A side-by-side comparison of China SXT Pharmaceuticals, Inc. and VivoSim Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SXTC
China SXT Pharmaceuticals, Inc.
$1.23HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
VIVS
VivoSim Labs, Inc.
$0.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SXTC vs VIVS
growth of $100 · dividends reinvested · last 1ySXTC -99.9% (-99.9%/yr)VIVS -78.7% (-78.7%/yr)VIVS compounded faster over this window
Log scale — wide-divergence pair
SXTC VIVS
Metrics side by side
Total return (annualized)
| Metric | SXTC | VIVS |
|---|---|---|
| Total return (1Y) | N/A | -93.85% |
SXTC is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.